HempFusion to Ring Today’s Opening Bell of the Toronto Stock Exchange
HempFusion Wellness Inc. (TSX:CBD.U) celebrates its listing on the Toronto Stock Exchange (TSX) by virtually ringing the opening bell today at 9:30 a.m. ET. The company successfully completed a $17,000,000 initial public offering and began trading on January 6, 2021. Co-founder and CEO Jason Mitchell expressed gratitude for the opportunity to ring the bell, alongside senior management and board members. HempFusion distributes its CBD products and has a strong focus on research and development, with 46 SKUs already available and an additional 30 products in development.
- Successful IPO raising $17,000,000.
- Listing on the TSX enhances visibility and credibility.
- Diverse product portfolio with 46 SKUs and 30 more under development.
- Strong distribution network across approximately 4,000 retail locations.
- None.
HempFusion Wellness Inc. (TSX:CBD.U) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, will celebrate the Company’s listing on the Toronto Stock Exchange (“TSX”) by virtually ringing the TSX opening bell at 9:30 a.m. ET today. As previously announced, HempFusion completed its
“It’s an honor to complete our initial public offering and listing on Canada’s most senior stock exchange, and we greatly appreciate the opportunity to ring the opening bell this morning,” commented Jason Mitchell N.D., HempFusion’s co-founder and CEO.
Dr. Mitchell will be joined in the virtual ceremony by the Company’s senior management, board of directors and other key HempFusion team members.
A live webcast of the TSX opening bell ceremony will be available beginning shortly before 9:30 a.m. ET on BNN Bloomberg.
ABOUT HEMPFUSION
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex™ and are available in-store or by visiting HempFusion online at www.hempfusion.com or www.probulin.com.
Follow HempFusion on Twitter, Facebook and Instagram and Probulin on Twitter, Facebook and Instagram.
Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210122005074/en/
FAQ
What is the significance of HempFusion's listing on TSX (CBD.U)?
How much money did HempFusion raise in its IPO?
What time did HempFusion ring the opening bell on the TSX?
What products does HempFusion offer?
How many retail locations does HempFusion distribute to?
